9 Future drug developments targeting menopausal weight gain include other oral and injectable GLP-1 agonists, orforglipron and danuglipron, ecnoglutide and mazdutide
Its long-term effects could have high impact on slowing aging (5)
Ethical Approval Not applicable Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
However, an attorney can still help them seek the compensation they deserve for their Ozempic-related losses
As in T2D, APD-induced increases in circulating insulin are hypothesized to desensitize insulin-sensitive peripheral targets (e.g., liver, skeletal muscle, adipose tissue) over time, resulting in insulin resistance and weight gain 3,4,15
Can I Take Them Together Safely